New IV stopper aims to cut catheter complications in hospitals
NCT ID NCT07519304
First seen Jun 27, 2026 · Last updated Sep 21, 2026 · Updated 1 time
Summary
This study tests a needle-free connector with anti-reflux technology, a special stopper that prevents blood from flowing back into IV catheters. The goal is to see if it reduces complications like blockages, infections, and pain compared to standard connectors. The trial will involve 62 hospitalized adults who need a long peripheral catheter for at least a week.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Needle-free connector with anti-reflux technology (Clave™ Neutron™)
- What this could lead to
- If it works, this could reduce catheter-related complications such as blockages, infections, and pain, improving patient comfort and safety during hospital stays.
- What could go wrong
- This is a small early-stage trial with only 62 participants, so results may not apply to all patients. The device may not significantly reduce complications compared to standard connectors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 62 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients requiring placement of a long peripheral venous catheter. * Patients who have provided written informed consent. * Patients with an expected hospital stay of ≥7 days. Exclusion Criteria: \- Inability to place a long peripheral venous catheter in the upper limbs.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Catheters are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arnau de Vilanova University Hospital in Lleida
Lleida, Lleida, 25198, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Session therapy course ease the mental load on parents of medically complex children?
- Can a bedside clotting test predict which brain tumor patients face deadly blood clots?
- AI reads x-rays to pinpoint catheter tips, no extra scans needed
- Can a new device suck out deadly lung clots?
- Simulated patients, real skills: a new training approach for future nurses
- Can a sedative help rebuilt tissue survive after cancer surgery?